Maria Loreta Foschini

Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

Renzo Galanello, Antonio Piga, Gian Luca Forni et al. · PubMed · 2006 · 139 citations

The effect of puberty on insulin resistance in obese children

Sabrina Pilia, Maria Rosaria Casini, Maria Loreta Foschini et al. · Journal of Endocrinological Investigation · 2009 · 68 citations

Insulin Resistance, Obesity, Metabolic Syndrome +12

Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major

Raffaella Origa, Fabrice Danjou, S. Cossa et al. · British Journal of Haematology · 2013 · 37 citations

Thalassemia major between liver and heart: Where we are now

Carlo Dessì, GiovanBattista Leoni, Paolo Moi et al. · Blood Cells Molecules and Diseases · 2015 · 24 citations

Hepatology, Physiology, Hematology +2

GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic–pituitary connections

Mohamad Maghnie, Maria Cristina Pennati, Elisa Civardi et al. · European Journal of Endocrinology · 2007 · 21 citations · Full text